Parkell CONTINUING EDUCATION

PARKELL CE JANUARY 2012

Sinus Bone Augmentation: A Review of the Common Techniques

CREDITS: 2

COST: $0.00

SOURCE: Parkell Online Learning Center

VIEW COURSE

READ ABSTRACT This article describes the biology and techniques of the sinus augmentation procedure. Most of the commonly used augmentation procedures aimed at restoring the atrophic posterior maxilla are presented through a serried of clinical cases. This article also discusses the drawbacks and complications associated with sinus bone grafts along with pertinent literature supporting their validity and long-term success.

READ LEARNING OBJECTIVES

• describe the anatomy and physiology of the sinus.
• choose the proper sinus lift technique(s), depending on the amount of residual bone.
• list the indications and contraindications of performing sinus lift procedures.
• explain complications that may arise during or after sinus lift procedures.

PARKELL CE NOVEMBER/DECEMBER 2011

A New Era in Periodontal and Peri-Implant Regeneration: Use of Growth-Factor Enhanced Matrices Incorporating rhPDGF

Samuel E. Lynch, DMD, DMSc; Leslie Wisner-Lynch, DMD, DMSc; Myron Nevins, DDS; Marc L. Nevins, DMD, MMSc

CREDITS: 2

COST: $0.00

SOURCE: Parkell Online Learning Center

VIEW COURSE

READ ABSTRACT A powerful off-the-shelf bone and tissue regeneration technology termed Growth-Factor Enhanced Matrix has become available for clinical use. This graft material consists of a concentrated solution of pure recombinant human platelet-derived growth factor (rhPDGF-BB), the synthetic form of the body’s key natural wound healing stimulator PDGF-BB, and an osteoconductive (bone scaffold) matrix. This is the first purified, recombinant (synthetic) growth factor product to be commercially available and is the result of over a decade of extensive research. Clinical and animal study results with this graft material demonstrate that it is capable of simultaneously promoting regeneration of bone and accelerating soft-tissue attachment gain in challenging periodontal and peri-implant defects.

READ LEARNING OBJECTIVES

• discuss why platelet-derived growth factor (PDGF) is one of the body's main initiators of healing.
• describe the background and efforts made to develop purified recombinant human PDGF for routine clinical use in periodontal and oral surgical procedures.
• explain the benefit of using recombinant human PDGF-BB with synthetic matrices for bone and gingival tissue regeneration.

Hiroyasu Endo, DDS, PhD; Terry D. Rees, DDS, MSD

Samuel DeAngelo, DDS, MS; James Murphy, DDS, MS; Lewis Claman, DDS, MS; John Kalmar, DMD, PhD; Binnaz Leblebicioglu, DDS, MS, PhD

Vanchit John, DDS, MSD, Robert De Poi, DDS, MSD, Steven Blanchard, DDS, MS